الفهرس 
Anatomy of Intestinal Blood SupplyOnly 14 pages are availabe for public view
 |  | from | 186 |  |  |
| | | from | 186 | | |
Abstract
Since 1958, Open treatment (OT) of symptomatic CMI has been the gold standard of management. However, nowadays, mesenteric angioplasty and stenting is the first choice of treatment in patients with CMI who have suitable lesions, independent of their clinical risk. The ideal lesion for angioplasty and stenting is a short, focal stenosis or occlusion with minimal to moderate calcification or thrombus.
The decision between open surgical (OS) and endovascular therapy (ET) is nuanced and a careful review of preprocedure CTA with attention to lesion anatomy, nutritional status, and life expectancy. ET is generally preferred as a first choice of treatment for CMI given the low rates of preoperative morbidity and mortality compared to OS.
In most recent results of studies about the management of CMI clarified that ER has similar preoperative mortality and shorter hospitalization but higher rate of restenosis requiring reintervention compared with OR. Patients with ER who required reintervention appear to have longer lesions as well as higher rates of aortic occlusive disease on preoperative angiography. Patients crossed over from ER to OR had higher preoperative mortality than either primary open or endovascular patients. These findings may guide treatment selection in patients with CMI undergoing ER or OR.